Återgå till huvudnavigering Återgå till sök Gå direkt till huvudinnehållet

Trajectories and Predictors of Depression After Breast Cancer Diagnosis: A 1-year longitudinal study

  • Eugenia Mylona
  • , Konstantina Kourou
  • , Georgios Manikis
  • , Haridimos Kondylakis
  • , Kostas Marias
  • , Evangelos Karademas
  • , Paula Poikonen-Saksela
  • , Ketti Mazzocco
  • , Chiara Marzorati
  • , Ruth Pat-Horenczyk
  • , Ilan Roziner
  • , Berta Sousa
  • , Albino Oliveira-Maia
  • , Panagiotis Simos
  • , Dimitrios I. Fotiadis

Forskningsoutput: Kapitel i bok/rapport/konferenshandlingKonferensbidragVetenskapligPeer review

Sammanfattning

Being diagnosed with breast cancer (BC) can be a traumatic experience for patients who may experience symptoms of depression. In order to facilitate the prevention of such symptoms, it is crucial to understand how and why depressive symptoms emerge and evolve for each individual, from diagnosis through treatment and recovery. In the present work, data from a multicentric study of 706 BC patients followed for 12 months are analyzed. First, a trajectory-based unsupervised clustering based on K-means is performed to capture the dynamic patterns of change in patients' depressive symptoms after BC diagnosis and to identify distinct trajectory clusters. Then a supervised learning approach was employed to build a classification model of depression progression and to identify potential predictors. Patients were clustered into 4 groups: stable low, stable high, improving, and worsening depressive symptoms. In a nested cross-validation pipeline, the performance of the Support Vector Machine model for discriminating between 'good' and 'poor' progression was 0.78±0.05 in terms of AUC. Several psychological variables emerged as highly predictive of the evolution of depressive symptoms with the most important ones being negative affectivity and anxious preoccupation. Clinical Relevance - The findings of the present study may help clinicians tailor individualized psychological interventions aiming at alleviating the burden of these symptoms in women with breast cancer and improving their overall well-being.

Originalspråkengelska
Titel på värdpublikation44th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBC 2022
Antal sidor4
FörlagInstitute of Electrical and Electronics Engineers Inc.
Utgivningsdatum2022
Sidor69-72
ISBN (elektroniskt)978-1-7281-2782-8
DOI
StatusPublicerad - 2022
MoE-publikationstypA4 Artikel i en konferenspublikation
Evenemang44th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBC 2022 - Glasgow, Storbritannien
Varaktighet: 11 juli 202215 juli 2022

Publikationsserier

NamnProceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBS
Volym2022-July
ISSN (tryckt)1557-170X

Bibliografisk information

Publisher Copyright:
© 2022 IEEE.

Vetenskapsgrenar

  • 3122 Cancersjukdomar

Citera det här